Page last updated: 2024-11-07

spironolactone and Adenohypophyseal Diseases

spironolactone has been researched along with Adenohypophyseal Diseases in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DAVID, M1
LASZLO, F1
KOVACS, K2
DAVID, MA1
LASZLO, FA1

Other Studies

2 other studies available for spironolactone and Adenohypophyseal Diseases

ArticleYear
[The role of the pituitary in the effect of spironolactone on water and electrolyte diuresis].
    Kiserletes orvostudomany, 1963, Apr-02, Volume: 15

    Topics: Diuresis; Electrolytes; Humans; Pituitary Diseases; Pituitary Gland; Spironolactone; Water; Water-El

1963
The role of the pituitary in the effect of spironolactone on water and electrolyte excretion.
    Acta physiologica Academiae Scientiarum Hungaricae, 1962, Volume: 22

    Topics: Body Fluids; Electrolytes; Hypophysectomy; Pituitary Diseases; Pituitary Gland; Spironolactone; Wate

1962
chemdatabank.com